Becton Dickinson India (BD India), a global leader in medical supplies launched a unique shielded cannula BD Insyte-W Autoguard, which reduces the sharp injuries to the healthcare workers substantially. BD is also launching BD Venflon Pro, a ported IV catheter and BD Veca-C, a fixation dressing for the IV Cannulae - all new generation products for better patient comfort.

The unique feature of BD Insyte-W Autoguard is its patented BD Autoguard Push Button Shielding Technology, which is meant to effectively safeguard healthcare workers from accidental needle stick injury. These injuries are the main source of transmission of infectious diseases in the healthcare workers.

The product uses specific material BD Vialon to make the catheter. It is proven in multiple clinical studies over ten years that IV Catheters made of BD Vialon biomaterial are easier to insert, while providing longer indwelling time with improved patient outcomes.

The product will be supported by a range of education and training programs on the product usage for paramedic staff. This program will focus on improved clinical knowledge and practice associated with IV therapy and cannulation.

At press briefing, Rakesh Kumar, general manager, BD India said, "BD is committed to promote the safety of Healthcare workers. We have been introducing the innovative products, which are safe, provide greater healthcare worker safety and deliver superior patient care. BD Insyte-W Autoguard, BD Venflon Pro and BD Veca C, based on extensive research, provides the top end choice to the patients."

The new products will redefine quality in IV Cannula, and are earmarked as growth drivers of the infusion therapy business of BD India.

BD Venflon Pro is a ported catheter, which has a unique feature - the catheter material, softens in blood stream by 75 per cent in just half an hour and reduces the irritation and other cannula related complications.

BD Veca -C is a sterile dressing designed for the use with IV Cannulae which has a unique high absorbing wound pad to keep the catheter insertion site dry, so that the risk of bacterial growth is minimized.

Becton Dickinson started operations in India in 1997 and the operations here are part of the $4 billion healthcare giant serves healthcare institutions, life science researchers, clinical laboratories, industry and general public through its safe and innovative products.